Page 564 - Read Online

Page 8 of 8 Puckett et al. J Cancer Metastasis Treat 2020;6:11 I http://dx.doi.org/10.20517/2394-4722.2020.98

83.
19. Embuscado EE, Laheru D, Ricci F, et al. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic
pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther 2005;4:548-54.
20. Tsurusaki M, Numoto I, Oda T, et al. Assessment of Liver Metastases Using CT and MRI Scans in Patients with Pancreatic Ductal
Adenocarcinoma: Effects of Observer Experience on Diagnostic Accuracy. Cancers (Basel) 2020;12.
21. Danet IM, Semelka RC, Nagase LL, Woosely JT, Leonardou P, Armao D. Liver metastases from pancreatic adenocarcinoma: MR imaging
characteristics. J Magn Reson Imaging 2003;18:181-8.
22. Renz BW, Boeck S, Roeder F, Trumm C, Heinemann V, Werner J. Oligometastatic Disease in Pancreatic Cancer - How to Proceed? Visc
Med 2017;33:36-41.
23. Tempero MA. NCCN Guidelines Updates: Pancreatic Cancer. J Natl Compr Canc Netw 2019;17:603-5.
24. Hasuike Y, Tanigawa T, Yamada M, et al. A case report-advanced pancreas cancer with liver and lung metastases well controlled over one
year by combination therapy with systemic chemotherapy, radiation and hepatic arterial infusion in an outpatient setting. Gan To Kagaku
Ryoho 2008;35:2117-9.
25. Schullian P, Johnston EW, Putzer D, et al. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after
hepatic resection. Eur J Surg Oncol 2020;S0748-7983(20)30806-4.
26. Lee SJ, Kim JH, Kim SY, Won HJ, Shin YM, Kim PN. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases
after Curative Resection of Pancreatic Adenocarcinoma. Korean J Radiol 2020;21:316-24.
27. Sparchez Z, Mocan T, Hajjar NA, et al. Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of
hepatic metastases. A monocentric initial experience. Med Ultrason 2019;21:217-24.
28. Tachezy M, Gebauer F, Janot M, et al. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a
time of safe pancreatic operations in a retrospective multicenter analysis. Surgery 2016;160:136-44.
29. Frigerio I, Regi P, Giardino A, et al. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? Ann Surg
Oncol 2017;24:2397-403.
30. Klein F, Puhl G, Guckelberger O, et al. The impact of simultaneous liver resection for occult liver metastases of pancreatic
adenocarcinoma. Gastroenterol Res Pract 2012;2012:939350.
31. Alghamdi AA, Hasabullah MA, Alhusani AI, et al. Survival Outcome of Pulmonary Metastasectomy Among Patients with Sarcoma and
Colorectal Primary Cancers: A Single Institute Experience. Gulf J Oncolog 2018;1:56-60.
32. Nanji S, Karim S, Tang E, et al. Pulmonary metastasectomy for colorectal cancer: predictors of survival in routine surgical practice. Ann
Thorac Surg 2018;105:1605-12.
33. Ampollini L, Gnetti L, Goldoni M, et al. Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting
survival. J Thorac Dis 2017;9:S1282-S90.
34. Arnaoutakis GJ, Rangachari D, Laheru DA, et al. Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of
outcomes and survival. J Gastrointest Surg 2011;15:1611-7.
35. Klempnauer J, Ridder GJ, Piso P, Pichlmayr R. Is liver resection in metastases of exocrine pancreatic carcinoma justified? Chirurg
1996;67:366-70.
36. Robinson LA, Tanvetyanon T, Springett G, et al. Pulmonary metastasectomy for suspected pancreaticobiliary cancer. J Thorac Cardiovasc
Surg 2016;152:75-82.
37. Downs-Canner S, Zenati M, Boone BA, et al. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas.
J Surg Oncol 2015;112:80-5.
38. Yamashita K, Miyamoto A, Hama N, Asaoka T, Maeda S, Omiya H, Takami K, Doki Y, Mori M, Nakamori S. Survival Impact of
Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma. Dig Surg 2015;32:464-71.
39. Wei M, Shi S, Hua J, Xu J, Yu X, Chinese Study Group for Pancreatic C. Simultaneous resection of the primary tumour and liver
metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a
multicentre, prospective, randomised phase III control trial (CSPAC-1). BMJ Open 2019;9:e033452.
40. Matsuki R, Sugiyama M, Takei H, et al. Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal
adenocarcinoma: a case report. Surg Case Rep 2018;4:26.